Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions

被引：67

作者：

Yozai, K ^{[1
]}

Shikata, K ^{[1
]}

Sasaki, M ^{[1
]}

Tone, A ^{[1
]}

Ohga, S ^{[1
]}

Usui, H ^{[1
]}

Okada, S ^{[1
]}

Wada, J ^{[1
]}

Nagase, R ^{[1
]}

Ogawa, D ^{[1
]}

Shikata, Y ^{[1
]}

Makino, H ^{[1
]}

机构：

[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008558, Japan

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2005年 / 16卷 / 11期

关键词：

D O I：

10.1681/ASN.2004111011

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Recent studies suggested the involvement of inflammatory processes in the pathogenesis of diabetic nephropathy. Methotrexate (MTX), a folic acid antagonist, is widely used for the treatment of inflammatory diseases. Recently, it has been shown that treatment with low-dose MTX reduces the cardiovascular mortality in patients with rheumatoid arthritis, suggesting that MTX has anti-atherosclerotic effects via its anti-inflammatory actions. This study was designed to determine the anti-inflammatory effects of this agent on diabetic nephropathy. Diabetes was induced in Sprague-Dawley rats with streptozotocin, and MTX (0.5 or 1.0 mg/kg) was administered once a week for 8 wk. Treatment with MTX reduced urinary albumin excretion, mesangial matrix expansion, macrophage infiltration, expression of TGF-beta and type IV collagen, and intercellular adhesion molecule-1 in glomeruli. MTX also reduced the high glucose-induced NF-kappa B activation in vitro and in vivo. The results indicate that intermittent administration of MTX prevented renal injuries without changes in blood glucose level and BP in experimental diabetic rats. The protective effects of MTX are suggested to be mediated by its anti-inflammatory actions through inhibition of NF-kappa B activation and consequent reduction of intercellular adhesion molecule-1 expression and macrophage infiltration. The results suggest that anti-inflammatory agents might be beneficial for the treatment of diabetic nephropathy.

引用

页码：3326 / 3338

页数：13

共 47 条

[41]

Suzuki Y, 1997, J RHEUMATOL, V24, P1890

[42] Expression of intercellular adhesion molecules 1 (ICAM-1) via an osmotic effect in human umbilical vein endothelial cells exposed to high glucose medium [J].

Taki, H ;

Kashiwagi, A ;

Tanaka, Y ;

Horiike, K .

LIFE SCIENCES, 1996, 58 (20) :1713-1721

[43] HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats [J].

Usui, H ;

Shikata, K ;

Matsuda, M ;

Okada, S ;

Ogawa, D ;

Yamashita, T ;

Hida, K ;

Satoh, M ;

Wada, J ;

Makino, H .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (02) :265-272

[44] Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes [J].

Utimura, R ;

Fujihara, CK ;

Mattar, AL ;

Malheiros, DMAC ;

Noronha, ID ;

Zatz, R .

KIDNEY INTERNATIONAL, 2003, 63 (01) :209-216

[45]

Weinblatt ME, 1998, J RHEUMATOL, V25, P238

[46] Methotrexate inhibits proliferation and regulation of the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by cultured human umbilical vein endothelial cells [J].

Yamasaki, E ;

Soma, Y ;

Kawa, Y ;

Mizoguchi, M .

BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (01) :30-38

[47] Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice [J].

Ziyadeh, FN ;

Hoffman, BB ;

Han, DC ;

Iglesias-de la Cruz, MC ;

Hong, SW ;

Isono, M ;

Chen, S ;

McGowan, TA ;

Sharma, K .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (14) :8015-8020

← 1 2 3 4 5 →